FFAR3 (GPR41) (N-Term) Polyclona

Confirm delete?

FFAR3 (GPR41) (N-Term) Polyclonal Antibody

Zoom

Cat No: 16104

GPR41 is a G protein-coupled receptor activated by short chain fatty acids (SCFAs).{25541,25605,25606} Several SCFAs have the potential to bind and activate GPR41, with pentanoate being the most potent agonist.{25605} GPR41 couples through the Pertuss...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Correlated keywords:

GPR41 shorts chains fatty acids inflammation colon adipose GPRs GPCR G proteins coupled receptors SCFAs pentanoate potent agonists pertussis toxins Gi/o tissues colonic lumen Ca2+ ERKs ERK1/2 ½ intestinal signals transduction western blots blotting WBs ELISA lipids mediators flows cytometry FC immunofluorescence antibodies calcium cAMP cyclic AMP FFAR3 Anti-FFAR3

Product Overview:
GPR41 is a G protein-coupled receptor activated by short chain fatty acids (SCFAs).{25541,25605,25606} Several SCFAs have the potential to bind and activate GPR41, with pentanoate being the most potent agonist.{25605} GPR41 couples through the Pertussis toxin-sensitive Gi/o family and its expression has been described in adipose tissue and the colonic lumen.{25606,25605,25541} The activation of GPR41 induces an increase in intracellular Ca2+, ERK1/2 activation and a decrease in intracellular cAMP.{25606,25605,25541} Activation of GPR41 may be involved in intestinal inflammation. The predicted size for GPR41 is 39 kDa. Cayman’s GPR41 (N-Term) Polyclonal Antibody detects a 43 kDa band by western blot in cell lysates.

Size	1 ea
Shipping	dry ice
Host	Rabbit
Antigen	Synthetic peptide from the N-terminal region of human GPR41
Application(s)	FC, IF, and WB
Formulation	500 µl of peptide affinity-purified polyclonal antibody
Custom Code	3822.19
UNSPSC code	12352203

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.